Abstract:Pancreatic cancer, predominantly pancreatic ductal adenocarcinoma (PDAC), is one of the most malignant tumors of the digestive system. Emerging evidence suggests the involvement of the microbiome and metabolic substances in the development of PDAC, yet the results remain contradictory. This study aims to identify the alterations and relationships in intratumoral microbiome and metabolites in PDAC. We collected matched tumor and normal adjacent tissue (NAT) samples from 105 PDAC patients and performed a 6-year follow-up. 2bRAD-M sequencing, untargeted liquid chromatography-tandem mass spectrometry, and untargeted gas chromatography-mass spectrometry were performed. Compared with NATs, microbial α-diversity decreased in PDAC tumors. The relative abundance of Staphylococcus aureus, Cutibacterium acnes, and Cutibacterium granulosum was higher in PDAC tumor after adjusting for confounding factors body mass index and M stage, and the presence of Ralstonia pickettii_B was found associated with a worse overall survival. Metabolomic analysis revealed distinctive differences in composition between PDAC and NAT, with 553 discriminative metabolites identified. Differential metabolites were revealed to originate from the microbiota and showed significant interactions with shifted bacterial species through KO (KEGG Orthology) genes. These findings suggest that the PDAC microenvironment harbors unique microbial-derived enzymatic reactions, potentially influencing the occurrence and development of PDAC by modulating the levels of glycerol-3-phosphate, succinate, carbonate, and beta-alanine. Importance: We conducted a large sample-size pancreatic adenocarcinoma microbiome study using a novel microbiome sequencing method and two metabolomic assays. Two significant outcomes of our analysis are: (i) commensal opportunistic pathogens Staphylococcus aureus, Cutibacterium acnes, and Cutibacterium granulosum were enriched in pancreatic ductal adenocarcinoma (PDAC) tumors compared with normal adjacent tissues, and (ii) worse overall survival was found related to the presence of Ralstonia pickettii_B. Microbial species affect the tumorigenesis, metastasis, and prognosis of PDAC via unique microbe-enzyme-metabolite interaction. Thus, our study highlights the need for further investigation of the potential associations between pancreatic microbiota-derived omics signatures, which may drive the clinical transformation of microbiome-derived strategies toward therapy-targeted bacteria.

Human microbiota colonization and pancreatic ductal carcinoma

Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review)

Microbiota Regulates Pancreatic Cancer Carcinogenesis through Altered Immune Response.

The Microbiota and Microbiome in Pancreatic Cancer: More Influential Than Expected

Microbiome and pancreatic ductal adenocarcinoma

Intratumoral microbiota of pancreatic ductal adenocarcinoma impact patient prognosis by influencing tumor microenvironment

Pancreatic Cancer Meets Human Microbiota: Close Encounters of the Third Kind

Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis

Unraveling the gut microbiome's contribution to pancreatic ductal adenocarcinoma: mechanistic insights and therapeutic perspectives

The correlation between gut and intra-tumor microbiota and PDAC: Etiology, diagnostics and therapeutics

The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer

The Microbiome in PDAC-Vantage Point for Future Therapies?

Current status and prospect of gut and oral microbiome in pancreatic cancer: Clinical and translational perspectives

Roles of microbiota in pancreatic cancer development and treatment

Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma

The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma

Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development

Research Progress of Pancreas-Related Microorganisms and Pancreatic Cancer

Association of the Microbiota and Pancreatic Cancer: Opportunities and Limitations

Intratumor Microbiome Analysis Identifies Positive Association Between Megasphaera and Survival of Chinese Patients With Pancreatic Ductal Adenocarcinomas

Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models